Smita Chandran - Memorial Sloan Kettering Cancer Center
Nat Med. 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
Read MoreSwathi Ramachandra Upadhya - University College Dublin
Cell Rep Methods. 2022
Experimental reproducibility limits the correlation between mRNA and protein abundances in tumor proteomic profiles
Read MoreMiao Yu - Fudan University
Nat Methods. 2021
SnapHiC: a computational pipeline to identify chromatin loops from single-cell Hi-C data
Read MoreOliver Eichmüller - Vienna Biocenter
Science. 2022
Amplification of human interneuron progenitors promotes brain tumors and neurological defects
Read MoreYu Zhang - National Cancer Institute
Nat Med. 2022
A T cell resilience model associated with response to immunotherapy in multiple tumor types
Read MoreLauritz Miarka - CNIO
Nat Med. 2022
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
Read MoreAditi Banerjee - Harvard Medical School
Neuron. 2022
Molecular and functional architecture of striatal dopamine release sites
Read MoreSofia Ferreira-Gonzalez - University of Edinburgh
Cell Stem Cell. 2022
Human biliary epithelial cells from discarded donor livers rescue bile duct structure and function in a mouse model of biliary disease
Read MoreIrene Ganan-Gomez - The University of Texas MD Anderson Cancer Center
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
Read More